SHEVINGTON SURGERY
HOUGHTON LANE, SHEVINGTON, WIGAN
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 51 | 63 | 81.0% | |
| HF 4 | 2011 | 52 | 61 | 85.2% | |
| HF 4 | 2012 | 56 | 67 | 83.6% | |
| HF 4 | 2013 | 55 | 67 | 82.1% | |
| HF004 | 2014 | 11 | 12 | 91.7% | |
| HF004 | 2015 | 9 | 9 | 100.0% | |
| HF004 | 2016 | 29 | 31 | 93.5% | |
| HF004 | 2017 | 28 | 29 | 96.6% | |
| HF004 | 2018 | 25 | 26 | 96.2% | |
| HF004 | 2019 | 30 | 32 | 93.8% | |
| HF004 | 2020 | 41 | 44 | 93.2% | |
| HF006 | 2021 | 66 | 70 | 94.3% | |
| HF006 | 2022 | 70 | 73 | 95.9% | |
| HF006 | 2023 | 81 | 82 | 98.8% |
